A propos d'un cas de rechute tardive de cancer du sein après traitement adjuvant
Laurence Lousberg(Centre Hospitalier Chrétien), Guy Jérusalem(Centre Hospitalier Universitaire de Liège), Joan Somja(University of Liège), Joëlle Collignon(Centre Hospitalier Universitaire de Liège), Christine Gilles(University of Liège)
RMLG. Revue médicale de Liège
January 1, 2011
Cited by 0
Related Papers
Triple-negative breast cancer: treatment challenges and solutions
|Breast Cancer Targets and Therapy|2016|382
Cardio-Oncology Services: rationale, organization, and implementation
|European Heart Journal|2018|303
Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis
|The Lancet Oncology|2019|193
β-Catenin and ZO-1: Shuttle Molecules Involved in Tumor Invasion-Associated Epithelial-Mesenchymal Transition Processes
|Cells Tissues Organs|2007|132
Human papillomavirus DNA strongly correlates with a poorer prognosis in oral cavity carcinoma
|The Laryngoscope|2012|112